Nilotinib Capsule
Product Images NDC 60505-3803

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 60505-3803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-150mg-500s (Btl Lbl 150mg 500s)

This packaging label is for Nilotinib Capsules 150 mg by Apotex Corp. It shows a bottle containing 500 capsules. The label states storage conditions, dispensing instructions, and dosage guidance, emphasizing taking the capsules on an empty stomach. Manufacturer details include Apotex Inc., Toronto, Canada, and Apotex Corp., Weston, Florida.*

FDA Label Image

Btl-lbl-200mg-500s (Btl Lbl 200mg 500s)

Label for Nilotinib Capsules 200 mg oral dosage form by Apotex Corp., containing 500 capsules. The label includes storage instructions and a pharmacist note about dispensing the medication guide. The product is manufactured by Apotex Inc. in Toronto, Canada and Apotex Corp. in Florida, USA. Barcodes and regulatory information are also present.*

FDA Label Image

Btl-lbl-50mg-120s (Btl Lbl 50mg 120s)

Label for Nilotinib Capsules 50 mg by Apotex Corp, containing 120 capsules. The label includes storage instructions to keep at 20°C to 25°C and dispense in a tight container. It states to take the capsules on an empty stomach, avoiding food 2 hours before and 1 hour after dose. The label also has the NDC 60505-3803-7 and a barcode.*

FDA Label Image

Fig-14-1 (Figure 14 1)

A Kaplan-Meier survival curve chart showing treatment-free survival percentage over time in weeks since treatment-free remission (TFR) for a patient group of 190. The chart includes a solid survival curve line with dashed confidence interval lines, censored observations marked, and an events-at-risk table indicating numbers of patients and events at various time points up to approximately 140 weeks.*

FDA Label Image

Fig-14-2 (Figure 14 2)

A Kaplan-Meier survival curve chart showing treatment-free survival percentage over time in weeks since therapy discontinuation (TFR). The graph includes a solid survival curve with dashed confidence intervals and markers indicating censored observations. Accompanying data at the bottom displays numbers at risk and events across different time points, with a total of 126 patients and 61 events noted.*

FDA Label Image

Inn-ctn-lbl-150mg-28s (Inn Ctn Lbl 150mg 28s)

Packaging label for Nilotinib Capsules 150 mg by Apotex Corp. The label indicates 28 unit-dose capsules (2 x 14) with NDC 60505-3801-0. It includes instructions to take capsules on an empty stomach, avoid food for at least 2 hours before and 1 hour after dosing. Marked for Rx only.*

FDA Label Image

Out-ctn-lbl-200mg-112s (Out Ctn Lbl 200mg 112s)

Nilotinib Capsules 200 mg oral capsules packaging label from Apotex Corp. The label indicates 4 individual blister packs with 28 capsules each. The label includes instructions to take capsules on an empty stomach and avoid food at least 2 hours before and 1 hour after dosing. It displays the NDC 60505-3802-2 and is marked Rx Only.*

FDA Label Image

Chemical Structure Of Nilotinib (Tasigna 01)

Chemical structure diagram of nilotinib hydrochloride monohydrate, showing the molecular layout including aromatic rings, heterocycles, and trifluoromethyl group, consistent with the active ingredient nilotinib.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.